Applying finite element analysis to high-spatial resolution 3-T MR images of proximal femur microarchitecture can enable detection of lower elastic modulus in subjects with fragility fractures, according to a study published online April 2 by Radiology.

Daily use of tadalafil does not result in improved erectile function amongst men undergoing radiotherapy for prostate cancer, according to a study published on April 2 by the Journal of the American Medical Association.

As the wait continues for improved breast screening methods, better understanding of associated harms, enhanced strategies for identification of high-risk patients, and tools to assist patients and clinicians in incorporating these factors into their decisions should be research priorities, according to a review published on April 2 by the Journal of the American Medical Association. 

Strand Genomics, the genomics software company in Rockville, Md., and San Francisco, Calif., announced April 1 that a selection of technology has been prepared for the company’s Strand Centers for Genomics and Personalized Medicine across the U.S.

A neural stem cell treatment is stepping up in the hopes of one day helping stroke patients regain more neurologic function.

Not only does alcoholism lead to neural atrophy and diminish total brain weight, but it also leads to a dramatic drop in the levels of select proteins in the brain, according to an article published April 3 in PLOS ONE.

Pittsburgh-based pharmaceutical research and development firm Cognition Therapeutics (CogRx) announced April 1 that the company’s patent for numerous drug therapy candidates have been approved.

Hypertension and other cardiovascular risk factors from early adulthood and beyond have a direct impact on future cognitive ability, according to a study published March 31 in Circulation.